Content

List volumes - List articles in this issue

Investigative Report

Indomethacin-induced Reduction in CRTH2 in Eosinophilic Pustular Folliculitis (Ofuji’s Disease): A Proposed Mechanism of Action

doi: 10.2340/00015555-0759

Abstract:

Eosinophilic pustular folliculitis is an inflammatory skin disease characterized by pruritic follicular papulo­pustules. It is usually resistant to topical and/or systemic corticosteroids, but it responds well to systemic indomethacin. We report here two patients with classical-type disease who were treated with systemic indomethacin. As indomethacin is an inhibitor of cyclo-oxygenases and a potent agonist of the prostaglandin D2 (PGD2) receptor, CRTH2 (chemoattractant receptor homologous molecule expressed on Th2 cells), we investigated the effects of indomethacin on CRTH2 expression by leukocytes. CRTH2 was expressed on blood eosinophils and lymphocytes. In vitro treatment with indomethacin suppressed the expression of CRTH2 on these cells. In addition, systemic treatment with indomethacin reduced eosinophil CRTH2 expression in another patient in association with improvement of skin lesions and blood eosinophilia. A number of inflammatory cells expressed haematopoietic PGD synthase, an essential enzyme for generating PGD2 in skin lesions of eosinophilic pustular folliculitis.
A PGD2-CRTH2 interaction may be involved in the patho­genesis. Moreover, indomethacin may exert its therapeutic effect via reducing CRTH2 expression, as well as by inhibiting PGD2 synthesis.

Authors:

Takahiro Satoh, Chieko Shimura, Chiyako Miyagishi and Hiroo Yokozeki

References

  • Fushimi M, Tokura Y, Sachi Y, Hashizume H, Sudo H, Wakita H, et al. Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Br J Dermatol 1996; 134: 766–772.
  • Ishiguro N, Shishido E, Okamoto R, Igarashi Y, Yamada M, Kawashima M. Ofuji’s disease: a report on 20 patients with clinical and histopathologic analysis. J Am Acad Dermatol 2002; 46: 827–833.
  • Lee ML, Tham SN, Ng SK. Eosinophilic pustular folliculitis (Ofuji’s disease) with response to indomethacin. Dermatology 1993; 186: 210–212.
  • Murakami M, Matsumoto R, Urade Y, Austen KF, Arm JP. c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. J Biol Chem 1995; 270: 3239–3246.
  • Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, Nagata K. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 2000; 164: 2277–2280.
  • Kanaoka Y, Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 163–167.
  • Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med. 2001; 193: 255–261.
  • Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O, et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 1999; 162: 1278–1286.
  • Nagata K, Hirai H, Tanaka K, Ogawa K, Aso T, Sugamura K, et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 1999; 459: 195–199.
  • Iwasaki M, Nagata K, Takano S, Takahashi K, Ishii N, Ikezawa Z. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 2002; 119: 609–616.
  • Okano M, Fujiwara T, Sugata Y, Gotoh D, Masaoka Y, Sogo M, et al. Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. Am J Rhinol 2006; 20: 342–348.
  • Satoh T, Moroi R, Aritake K, Urade Y, Kanai Y, Sumi K, et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006; 177: 2621–2629.
  • Ulven T, Receveur JM, Grimstrup M, Rist O, Frimurer TM, Gerlach LO, et al. Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits. J Med Chem 2006; 49: 6638–6641.
  • Uller L, Mathiesen JM, Alenmyr L, Korsgren M, Ulven T, Hogberg T, et al. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res 2007; 8: 16.
  • Shiraishi Y, Asano K, Niimi K, Fukunaga K, Wakaki M, Kagyo J, et al. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. J Immunol 2008; 180: 541–549.
  • Spik I, Brenuchon C, Angeli V, Staumont D, Fleury S, Capron M, et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 2005; 174: 3703–3708.
  • Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M, Nagata K. Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J Immunol 2002; 168: 981–985.
  • Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693–11697.
  • Satoh T, Kaneko M, Wu MH, Yokozeki H, Nishioka K. Contribution of selectin ligands to eosinophil recruitment into the skin of patients with atopic dermatitis. Eur J Immunol 2002; 32: 1274–1281.
  • Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, Urade Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 2002; 168: 443–449.
  • Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K. Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 2004; 316: 1009–1014.
  • Shimura C, Satoh T, Yokozeki H. Increased expression of hematopoietic prostaglandin D synthase in CCR4-positive T cells from patients with atopic dermatitis. Acta Derm Venereol 2008; 88: 506–508.
  • Yahara H, Satoh T, Miyagishi C, Yokozeki H. Increased expression of CRTH2 on eosinophils in allergic skin diseases. J Eur Acad Dermatol Venereol 2009 [Epub ahead of print].
  • Related articles

    There are no related articles.


    Share with your friends





    Actions


    Abstract

    Full text

    PDF

    Supplementary


    There is no supplementary for this article.

    Print information


    Volume 90, Issue 1

    DOI: 10.2340/00015555-0759

    Pages: 18-22

    View at PubMed